Deflazacort

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 554 publications

Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register data.

Disease progression and economic burden of duchenne muscular dystrophy: A retrospective study using Swedish register data.

Journal: Journal of neuromuscular diseases
Published: July 04, 2026

Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial.

Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial.

Journal: Neurology
Published: May 27, 2026

Prescription Patterns in Rheumatoid Arthritis Patients at a Tertiary Care Hospital: A Prospective Cross-Sectional Study.

Prescription Patterns in Rheumatoid Arthritis Patients at a Tertiary Care Hospital: A Prospective Cross-Sectional Study.

Journal: Cureus
Published: May 15, 2026

Effects of Sex and Fed State Differences on the Pharmacokinetics of Drugs in Humans.

Effects of Sex and Fed State Differences on the Pharmacokinetics of Drugs in Humans.

Journal: Drug research
Published: May 12, 2026

Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy.

Meta-analysis of clinical trials assessing the safety of pharmacological treatments for muscular degeneration in Duchenne muscular dystrophy.

Journal: BMC pharmacology & toxicology
Published: April 17, 2026

Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.

Balancing Benefits and Risks: Long-term Use of Daily versus Intermittent Corticosteroids in Duchenne Muscular Dystrophy.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 02, 2026

Post-marketing safety surveillance and signal characterization of the novel dissociative steroid Vamorolone in Duchenne muscular dystrophy: a comparative disproportionality analysis based on FAERS data.

Post-marketing safety surveillance and signal characterization of the novel dissociative steroid Vamorolone in Duchenne muscular dystrophy: a comparative disproportionality analysis based on FAERS data.

Journal: Frontiers in pharmacology
Published: March 25, 2026

Successful Management of a Chronic Pedal Ulcer Secondary to Snake Bite: A Case Report.

Successful Management of a Chronic Pedal Ulcer Secondary to Snake Bite: A Case Report.

Journal: Cureus
Published: February 24, 2026

Elimination Profile of Deflazacort and Metabolites in Urine and Plasma Following Oral Administration: Relevance to Sports Drug Testing.

Elimination Profile of Deflazacort and Metabolites in Urine and Plasma Following Oral Administration: Relevance to Sports Drug Testing.

Journal: Drug testing and analysis
Published: February 12, 2026

From case to caution: hyponatremia in a patient with Duchenne muscular dystrophy on vamorolone and lessons for clinicians.

From case to caution: hyponatremia in a patient with Duchenne muscular dystrophy on vamorolone and lessons for clinicians.

Journal: Neuromuscular disorders : NMD
Published: February 02, 2026

Survey of Adrenal Insufficiency Management for Duchenne muscular dystrophy in Italy.

Survey of Adrenal Insufficiency Management for Duchenne muscular dystrophy in Italy.

Journal: Endocrine
Published: January 22, 2026

Management of Duchenne Muscular Dystrophy in Clinical Practice: A Survey-Based Study in Spain.

Management of Duchenne Muscular Dystrophy in Clinical Practice: A Survey-Based Study in Spain.

Journal: Neurology and therapy
Published: December 30, 2025
Showing 1-12 of 554

Last Updated: 09/26/2026